Correlation Between Pulmatrix and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and AN2 Therapeutics, you can compare the effects of market volatilities on Pulmatrix and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and AN2 Therapeutics.
Diversification Opportunities for Pulmatrix and AN2 Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pulmatrix and AN2 is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Pulmatrix and AN2 Therapeutics
Given the investment horizon of 90 days Pulmatrix is expected to generate 2.72 times more return on investment than AN2 Therapeutics. However, Pulmatrix is 2.72 times more volatile than AN2 Therapeutics. It trades about 0.34 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.32 per unit of risk. If you would invest 220.00 in Pulmatrix on September 1, 2024 and sell it today you would earn a total of 444.00 from holding Pulmatrix or generate 201.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pulmatrix vs. AN2 Therapeutics
Performance |
| Timeline |
| Pulmatrix |
| AN2 Therapeutics |
Pulmatrix and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pulmatrix and AN2 Therapeutics
The main advantage of trading using opposite Pulmatrix and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |